Healthcare -
Biotechnology - NASDAQ - US
$ 2.95
-10.3 %
$ 2.15 B
Market Cap
-3.28
P/E
IBRX - OTHER CURRENT ASSETS
Other Current Assets IBRX - ImmunityBio, Inc.
24.5 M
LAST VALUE
24.02%
2 YEAR CAGR
58.37%
5 YEAR CAGR
58.27%
10 YEAR CAGR